Literature DB >> 310294

Candida endophthalmitis after intravenous drug abuse.

G L Aguilar, M S Blumenkrantz, P R Egbert, J P McCulley.   

Abstract

Patients with endogenous Candida endophthalmitis associated with intravenous (IV) drug abuse may manifest ocular and systemic signs different from those seen in other forms of endogenous Candida endophthalmitis. There may be a sparcity of evidence of systemic candidiasis, including negative serology and normal physical examination results. Anterior uveitis and extensive vitreous involvement are common and do not necessarily have associated typical retinal lesions, which are more commonly seen in the compromised host. This may occur either because of the more transitory nature of choroidal or retinal lesions or because these patients often seek treatment at later stages. Even with a typical clinical picture, it is difficult to get culture confirmation of the diagnosis. Material obtained by vitrectomy must be concentrated before inoculation of media because of the known difficulty of culturing Candida from the vitreous cavity.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 310294     DOI: 10.1001/archopht.1979.01020010036008

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  18 in total

1.  Presumed ocular candidiasis in drug misusers after intravenous use of oral high dose buprenorphine (Subutex).

Authors:  N Cassoux; B Bodaghi; P Lehoang; Y Edel
Journal:  Br J Ophthalmol       Date:  2002-08       Impact factor: 4.638

2.  Candida endophthalmitis: clinical presentation, treatment and outcome in 23 patients.

Authors:  S Schmid; A C Martenet; O Oelz
Journal:  Infection       Date:  1991 Jan-Feb       Impact factor: 3.553

3.  An Outbreak of Endogenous Fungal Endophthalmitis Among Intravenous Drug Abusers in New England.

Authors:  Aubrey R Tirpack; Jay S Duker; Caroline R Baumal
Journal:  JAMA Ophthalmol       Date:  2017-06-01       Impact factor: 7.389

Review 4.  Common ocular infections. A prescriber's guide.

Authors:  S P Donahue; J M Khoury; R P Kowalski
Journal:  Drugs       Date:  1996-10       Impact factor: 9.546

5.  Candida endophthalmitis.

Authors:  H M Towler; S Lightman; M Matheson
Journal:  Br J Ophthalmol       Date:  1995-12       Impact factor: 4.638

6.  Congenital stationary nightblindness in a patient with osteopetrosis.

Authors:  Y Matsui; S Okinami; S Oono; M Matsui
Journal:  Br J Ophthalmol       Date:  1995-12       Impact factor: 4.638

7.  Candidal endophthalmitis: a manifestation of systemic candidiasis.

Authors:  B C Patel; S B Kaye; L H Morgan
Journal:  Postgrad Med J       Date:  1987-07       Impact factor: 2.401

8.  Penetration of new azole compounds into the eye and efficacy in experimental Candida endophthalmitis.

Authors:  D V Savani; J R Perfect; L M Cobo; D T Durack
Journal:  Antimicrob Agents Chemother       Date:  1987-01       Impact factor: 5.191

9.  Candida endophthalmitis after heroin abuse.

Authors:  F Malecaze; J L Arne; P Bec; J P Séguéla; M D Linas; P Recco; M H Béssières
Journal:  Mycopathologia       Date:  1985-11       Impact factor: 2.574

Review 10.  Uveitis. A review.

Authors:  C Y Lowder; D H Char
Journal:  West J Med       Date:  1984-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.